Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:NGVT
NYSE:NGVTChemicals

Ingevity (NGVT) Q1 EPS Rebound Tests Bulls’ Profit Turnaround Narrative

Ingevity (NGVT) opened 2026 with Q1 revenue of US$258 million and basic EPS of US$0.66, supported by net income excluding extra items of US$23.4 million and earnings from discontinued operations of US$36.4 million. The company has seen quarterly revenue move from US$340.1 million and EPS of a US$1.54 loss in Q1 2024 to US$284 million and EPS of US$0.56 in Q1 2025, landing at US$258 million and EPS of US$0.66 in Q1 2026, while trailing 12 month figures still reflect a loss, with basic EPS at a...
TSE:9064
TSE:9064Logistics

Yamato Holdings (TSE:9064) Valuation After Full Year Results Reveal Revenue Growth But Weaker Earnings

Full year earnings snapshot and why it matters for Yamato Holdings stock Yamato Holdings (TSE:9064) has released full year results to March 31, 2026, reporting sales of ¥1,865,675 million, net income of ¥13,662 million, and basic EPS of ¥43.07 from continuing operations. See our latest analysis for Yamato Holdings. The earnings release appears to have shifted sentiment in the short term, with a 1-day share price return of 4.23% to ¥1,822.5. However, the 1-year total shareholder return of a...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

AI-Fueled Growth And Convertible Notes Could Be A Game Changer For ON Semiconductor (ON)

Earlier this month, ON Semiconductor completed a US$1.30 billion Rule 144A private placement of 0% Convertible Senior Notes due 2031, featuring attached guarantees, zero coupons, and potential equity conversion, while also repurchasing millions of shares under its existing buyback program. The financing coincides with stronger-than-expected first-quarter results led by AI data center and automotive demand, alongside expanded silicon carbide collaborations with NIO and Geely that deepen ON’s...
NasdaqGS:CRTO
NasdaqGS:CRTOMedia

Criteo (CRTO) Is Down 13.1% After Weak Q1 2026 Results And Redomiciliation Plan - What's Changed

Criteo S.A. has reported past first-quarter 2026 results showing sales of US$424.64 million versus US$451.43 million a year earlier, with net income falling to US$7.82 million from US$37.93 million and diluted EPS from continuing operations declining to US$0.15 from US$0.66. Alongside weaker Retail Media performance and lower profitability, Criteo is proceeding with a legal redomiciliation to Luxembourg aimed at easing buyback constraints and improving access to U.S. capital markets. We’ll...
NasdaqGS:DASH
NasdaqGS:DASHHospitality

DoorDash (DASH) Q1 Net Margin At 6.3% Tests Bullish Profitability Narrative

Q1 2026 results set the scene DoorDash (DASH) opened 2026 with Q1 revenue of US$4.0 billion and basic EPS of US$0.42, setting a clear benchmark for how the business is currently converting its scale into per share profitability. The company has seen quarterly revenue move from US$2.9 billion in Q4 2024 to US$3.0 billion in Q1 2025 and then to US$4.0 billion in Q1 2026, while basic EPS over the same period went from US$0.34 to US$0.46 and then US$0.42, giving investors a clean view of how...
NYSE:AMC
NYSE:AMCEntertainment

Did Arena One Concerts and Note‑for‑Equity Swap Just Shift AMC Entertainment Holdings' (AMC) Investment Narrative?

In early May 2026, AMC Entertainment Holdings reported first‑quarter revenue of US$1,045.4 million, up from US$862.5 million a year earlier, while reducing its net loss to US$117.1 million and announcing the full exchange of US$155.8 million of senior secured notes into equity. At the same time, AMC rolled out Arena One, a live interactive concert series across more than 300 U.S. theatres, and expanded content partnerships such as its Netflix “Narnia” deal, aiming to broaden attendance and...
ASX:ANN
ASX:ANNMedical Equipment

Is Ansell’s (ASX:ANN) Ongoing Buy‑Back Quietly Redefining Its Capital Allocation Playbook?

Ansell Limited has updated investors on its on-market share buy-back, confirming that nearly 2.9 million shares have been repurchased since the program began in December 2025. This ongoing reduction in the share count highlights how Ansell is actively using its balance sheet to support capital returns and potential earnings-per-share accretion. We’ll now explore how Ansell’s continued on-market buy-back activity shapes its investment narrative and outlook for capital allocation...
NYSE:SNDR
NYSE:SNDRTransportation

Is Schneider National (SNDR) Pricing Make Sense After 35% One Year Share Gain

If you are wondering whether Schneider National's current share price lines up with its fundamentals, starting with a clear view of value can help you decide how it fits into your portfolio. The stock most recently closed at US$30.65, with returns of 11.7% over the last 30 days, 13.6% year to date and 35.2% over the past year. Over the last 7 days it declined 1.4%, while its 3-year return is 21.2% and its 5-year return is 28.7%. Recent news around Schneider National has focused on its role...
NYSE:LNG
NYSE:LNGOil and Gas

Cheniere Energy Q1 Loss Of US$3.5b Tests Bullish Contract Stability Narrative

Cheniere Energy (LNG) opened Q1 2026 with revenue of US$5.9b and a basic EPS loss of US$16.64, compared with Q1 2025 revenue of US$5.4b and basic EPS of US$1.57. Trailing twelve month EPS sits at US$6.75 on revenue of US$19.9b. Over the last few quarters, revenue has moved from US$4.5b in Q4 2024 to US$5.0b in Q4 2025 and EPS has ranged from US$4.35 to US$10.72 before this latest quarterly loss. This leaves investors weighing a fuller year of positive EPS against a tough quarter for margins...
NYSE:AME
NYSE:AMEElectrical

AMETEK’s $5b Indicor Deal Tests Valuation And Growth Thesis

AMETEK (NYSE:AME) announced a $5 billion acquisition of Indicor Instrumentation, expanding its reach in industrial and scientific instrumentation. The deal is described by the company as transformative for its mission critical instrumentation portfolio and recurring revenue exposure. This transaction is one of the largest in AMETEK’s history and is expected to reshape its long term revenue mix and operating profile. For investors tracking NYSE:AME, this announcement comes with the stock at...
NYSE:FLS
NYSE:FLSMachinery

Will Flowserve’s (FLS) Debt-Funded Trillium Deal And Lower Guidance Change Its Margin Progress Narrative?

In early May 2026, Flowserve Corporation completed a US$500 million offering of 5.70% senior unsecured notes due 2036, primarily to fund its planned acquisition of Trillium Flow Technologies’ Valves Division and for general corporate purposes, alongside reporting first-quarter sales of US$1,068.27 million and net income of US$81.68 million. At the same time, the company lowered its 2026 total sales growth guidance to a range of 3% to 6%, signaling a more cautious outlook even as it pursues...
NYSE:ARES
NYSE:ARESCapital Markets

Will Ares’ Record Q1 Fundraising, Higher Dividend and New COO Change Ares Management’s (ARES) Narrative?

Ares Management Corporation has already reported first-quarter 2026 results, with revenue rising to US$1,396.44 million and net income to US$142.59 million, while also lifting its quarterly common dividend to US$1.35 per share and maintaining preferred dividends. The appointment of Peter Ogilvie as Chief Operating Officer and Head of Strategy, alongside record fundraising and expanding assets under management, highlights Ares’ focus on scaling its global alternatives platform and reinforcing...
NasdaqGS:CTLP
NasdaqGS:CTLPDiversified Financial

Cantaloupe (CTLP) Q3 Loss Deepens And Tests Bullish High‑Growth Narratives

Cantaloupe (CTLP) has just posted its Q3 2026 numbers, reporting revenue of US$78.7 million, a basic EPS loss of US$0.03 and a net income loss of US$2.4 million. These figures set the tone for this quarter’s update. The company’s quarterly revenue has moved from US$73.7 million and EPS of US$0.07 in Q2 2025 to around US$78.7 million and an EPS loss of US$0.03 in Q3 2026, while trailing 12 month EPS sits at US$0.04 on revenue of US$320.8 million. With trailing profitability thin and recent...
NYSE:AGM
NYSE:AGMDiversified Financial

Does Federal Agricultural Mortgage (AGM)’s Stronger EPS Signal a Turning Point in Its Profitability Story?

Federal Agricultural Mortgage Corporation recently reported past first-quarter 2026 results, with net income rising to US$59.12 million from US$49.65 million a year earlier. Stronger basic and diluted earnings per share from continuing operations highlight how the company’s profitability improved compared with the prior-year quarter. With this earnings improvement in focus, we’ll now examine how the stronger profitability profile may influence Federal Agricultural Mortgage’s investment...
OB:EQNR
OB:EQNROil and Gas

Equinor (OB:EQNR) Margin Compression Challenges Bullish Profitability Narratives After Q1 2026 Results

Equinor (OB:EQNR) opened 2026 with Q1 revenue of US$27.8b and basic EPS of US$1.24, alongside net income of US$3.1b and a realized hedged oil price of US$78.6 per barrel. Over recent quarters, revenue has moved between US$25.1b and US$29.4b while basic EPS ranged from a loss of US$0.08 to a high of US$0.97. This gives you a clear view of how earnings have tracked through shifting price and volume conditions. With a trailing net margin of 5.3% compared with 8.2% a year earlier, the latest...
NYSE:IIPR
NYSE:IIPRIndustrial REITs

Does Refinancing With a Secured SOFR Loan Change The Bull Case For Innovative Industrial Properties (IIPR)?

Innovative Industrial Properties, Inc. recently closed a US$56.5 million secured, interest-only term loan tied to one-month SOFR plus 500 basis points, using the proceeds to refinance unsecured notes maturing this month. At the same time, the company reported first-quarter 2026 revenue of about US$69.0 million and net income of US$32.8 million, with funds from operations exceeding analyst expectations despite earlier concerns about tenant stress and liquidity. Against this backdrop, we’ll...
NYSE:PINS
NYSE:PINSInteractive Media and Services

Assessing Pinterest (PINS) Valuation As Shares Show Fresh Momentum

Why Pinterest stock is drawing fresh attention Pinterest (PINS) stock has quietly moved higher over the past month and past 3 months, putting its recent share performance, valuation, and underlying business trends back on many investors’ radars. See our latest analysis for Pinterest. Despite a recent 30 day share price return of 18.41% and a 90 day share price return of 9.95%, Pinterest’s year to date share price return of 18.86% decline and 1 year total shareholder return of 22.65% decline...
NYSE:MTD
NYSE:MTDLife Sciences

A Look At Mettler Toledo (MTD) Valuation After Steady Q1 2026 Earnings Performance

Q1 2026 earnings as the starting point Mettler-Toledo International (MTD) has just reported Q1 2026 sales of US$947.13 million and net income of US$169.45 million, with earnings per share from continuing operations slightly higher than a year earlier. See our latest analysis for Mettler-Toledo International. The latest Q1 report comes after a period where the stock has shown mixed momentum, with a 3.9% 30 day share price return but a 6.5% decline year to date, while the 1 year total...
NasdaqGS:ENTG
NasdaqGS:ENTGSemiconductor

How Investors Are Reacting To Entegris (ENTG) Strong Q1 Results, Upbeat Guidance, Expanded Credit Line, New CFO

Entegris, Inc. recently reported first-quarter 2026 results showing higher sales and net income year on year, issued stronger earnings guidance for the next two quarters, amended its revolving credit facility to US$750.00 million through 2031, and appointed industry veteran Sukhi Nagesh as CFO effective May 18, 2026. Together, these updates highlight Entegris’ focus on reinforcing its balance sheet, tightening operations, and deepening semiconductor-sector expertise in its finance leadership...
NYSE:TMO
NYSE:TMOLife Sciences

Thermo Fisher’s New Cell Therapy Bioreactor And Bioprocess Hub Might Change The Case For Investing In TMO

In April and early May 2026, Thermo Fisher Scientific expanded its bioproduction footprint by launching the Gibco CTS DynaXS Single Use Bioreactor for scalable cell therapy manufacturing and opening a flagship U.S. Bioprocess Design Center in Plainville, Massachusetts to support end-to-end biologics development. Together, these moves deepen Thermo Fisher’s role in cell and gene therapy workflows, expanding its ability to support customers from process design through cGMP manufacturing. We’ll...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health (CLOV) Quarterly Profit Challenges Longstanding Bearish Loss Narratives

Clover Health Investments (CLOV) opened Q1 2026 with revenue of US$749.2 million and basic EPS of US$0.05, alongside net income excluding extra items of US$27.3 million, giving investors a clean read on the core business. Over the last five reported quarters, revenue has moved from US$336.9 million in Q4 2024 to US$749.2 million in Q1 2026, while quarterly basic EPS has shifted from a loss of US$0.04 to a profit of US$0.05. This sets up this update as a key check on whether those improving...